10/16/2008 |
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
Jens Flensted Lassen, et al |
10/16/2008 |
Large-Scale Registry Examining Safety and Effectiveness of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
Michael Maeng, et al |
10/16/2008 |
A Polymer-Free Dual Drug-Eluting Stent in Patients with Coronary Artery Disease: Randomized Trial Versus Polymer-Based DES
Robert A. Byrne, MB MRCPI |
10/16/2008 |
The Spanish ESTROFA-2 Registry
Jose Mª de la Torre Hernandez, MD, PhD |
10/16/2008 |
EPIC Trial: Evaluating the Use of the FiberNet® Embolic Protection System In Carotid Artery Stenting
Subbarao Myla, MD FACC |
10/16/2008 |
EMPiRE: A Multicenter Registry Evaluating Neuroprotection During Carotid Stenting with a Novel Flow Reversal System
L. Nelson Hopkins, MD and Daniel Clair, MD |
10/16/2008 |
The DIVERGE Trial
Stefan Verheye, MD, PhD |
10/16/2008 |
BBC ONE
David Hildick-Smith |
10/16/2008 |
HORIZONS AMI: Harmonizing Outcomes with Revascularization and Stents in AMI
HORIZONS AMI |
10/16/2008 |
SYNTAX (SYNergy between PCI with TAXUS* and cardiac surgery)
Boston Scientific Corporation |
10/16/2008 |
First-in-Human Report: Initial Experience with a Stentless and Retrievable Percutaneous Aortic Valve Prosthesis
Joachim Schofer |
10/15/2008 |
The ZEST-AMI Trial: Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent vs. Sirolimus-Eluting Stent vs. PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients
Cheol Whan Lee and Seung-Jung Park |
10/15/2008 |
PROlonged Bivalirudin Infusion Versus Intraprocedural only RandomIzed study: The PROBI VIRI study
Bernardo Cortese, MD |
10/15/2008 |
The PREPARE Trial: A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary PCI
Karel T. Koch |
10/15/2008 |
NAPLES: Novel Approaches for Preventing or Limiting Event Study
Carlo Briguori, MD, PhD |
10/15/2008 |
HORIZONS AMI: A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction
Gregg W. Stone MD |
10/15/2008 |
HORIZONS AMI: A Prospective, Randomized Comparison of Bivalirudin vs. Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction
Roxana Mehran, MD |
10/15/2008 |
FATA Trial (Facilitated Angioplasty with Tirofiban or Abciximab)
Francesco Saia |
10/15/2008 |
ASSIST: A Safety and Efficacy Study of Integrilin Facilitated PCI versus Primary PCI in ST Elevation Myocardial Infarction
Michel Le May, MD |
10/15/2008 |
ARNO TRIAL (Antithrombotic Regimens aNd Outcome)
David Antoniucci |
10/15/2008 |
The Necessity of Surgical Backup for PCI
Sigmund Silber, MD, PhD, FACC, FESC |
10/15/2008 |
DES and DAP: How do the EU and US Guidelines Differ?
Sigmund Silber, MD, PhD, FACC, FESC |
10/14/2008 |
Long Term Safety Results from the Endeavor Program: Four Year Follow up
Laura Mauri, Donald Cutlip, Martin B Leon, David E Kandzari, William Wijns, Jean Fajadet, Joseph M Massaro, Wei Guo, Ian T Meredith |
10/14/2008 |
ODESSA - Optical Coherence Tomography for DES SAfety
ODESSA |
10/14/2008 |
The SOS (Stenting Of Saphenous vein grafts) Randomized, Controlled Trial of a Paclitaxel-Eluting Stent Vs. a Similar Bare Metal Stent in Saphenous Vein Graft Lesions
Emmanouil S. Brilakis, MD, PhD |
10/14/2008 |
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions
J. Mehilli, MD |
10/14/2008 |
Fractional Flow Reserve verses Angiography for Guiding PCI in Patients with Multivessel Coronary Artery Disease
Nico H.J.Pijls, MD, PhD |
10/14/2008 |
Endeavor IV: Two-Year Follow-up from a Prospective Randomized Trial Comparing a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Martin B. Leon, MD |
10/14/2008 |
Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Cilostazol) Significantly Reduces Ischemic Events after Drug-Eluting Stent Implantation: The DECREASE Registry
Seong-Wook Park, MD, PhD, FACC |
10/14/2008 |
COOL RCN: A Prospective, Randomized Trial Examining the Safety and Efficacy of Systemic Hypothermia for the Prevention of Radiocontrast Nephropathy
Gregg W. Stone, MD |
10/14/2008 |
The Safety of 6 6-Month and 12 12-Month Dual Anti Platelet Therapy in Patients Treated with a Zotarolimus Zotarolimus-eluting Stent: A Patient Patient-Level Pooled Analysis of 5 Endeavor Clinical Trials
Roxana Mehran, David E. Kandzari, Laura Mauri, Adriano Caixeta, George Dangas, Manuela Negoita and Martin B. Leon |
10/14/2008 |
The EVENT Registry – On and Off-label Experiences
Neal Kleiman |
10/14/2008 |
Three Year Outcomes Following Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in an Unselected Population with Coronary Artery Disease: The REWARDS Registry
Ron Waksman, Kimberly Kaneshige, Rebecca Torguson, Probal Roy, Zhenyi Xue, William Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard |
10/14/2008 |
DESERT (Drug-Eluting Stent Event Registry of Thrombosis)
Ron Waksman, MD |
10/14/2008 |
Two Year Follow-up with New Zotarolimus-eluting Stent: Endeavor Resolute
Ian T. Meredith, Stephen Worthley, Darren Walters, Robert Whitbourn, Peter J. Fitzgerald, Manuela Negoita, Jeffrey J. Popma |
10/14/2008 |
Zotarolimus Drug-eluting Stent in Patients with an Acute Myocardial Infarction: 12 Month Results from the E-Five Registry
Chaim Lotan, Ian T. Meredith, Manuela Negoita and Martin T. Rothman |
10/14/2008 |
12 Month Outcomes in Patients with Diabetes Implanted with an Endeavor Zotarolimus-eluting Stent: Results from the E-Five Registry
Martin T. Rothman, Ian T. Meredith, Minglei Liu and Chaim Lotan |